Jupiter Neurosciences Inc (NASDAQ:JUNS) does about 1.07M shares in volume on a normal day but saw 754164 shares change hands in the recent trading day. The company now has a market cap of 35.75M USD. Its current market price is $1.08, marking an increase of 11.36% compared to the previous close of $0.97. The 52 week high reached by this stock is $19.51 whilst the lowest price level in 52 weeks is $0.91.
Jupiter Neurosciences Inc (JUNS) has a 20-day trading average at $4.1375 and the current price is -94.46% off the 52-week high compared with 18.68% distance from its 52-week low. If we look at the stock’s price movements over the week, volatility stands at 16.39%, which increases to 29.92% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 31.15 to suggest the stock is neutral.
The consensus objective for the share price is $30.00, suggesting that the stock has a potential upside of 96.4% over the period.
The current price level is -73.90%, -85.03%, and -85.03% away from its SMA20, SMA50, and SMA200 respectively, with the JUNS price moving above the 50-day SMA on current market day. Jupiter Neurosciences Inc (JUNS) stock is down -18.18% over the week and -89.70% over the past month. Its price is -89.91% year-to-date.
The company’s next earnings report forecasts estimating quarterly EPS at -0.02 and -0.06 for whole year.
To reach the target analysts have set, the stock logically needs to grow 96.4 percent from here.
Outstanding shares total 33.10M with insiders holding 54.49% of the shares and institutional holders owning 0.00% of the company’s common stock.
